Piper Sandler Keeps Their Buy Rating on NovoCure (NVCR)
at www.tipranks.com (Fri, 30-Jan 7:26 AM)
Novocure Hits Record Revenues and Expands Patient Reach—What’s Fueling This Growth?
Market Chameleon (Mon, 12-Jan 9:41 AM)
